Novartis Investigative Site

Newnan, Georgia 30263

0 studies enrolling now · 5 studies all time

What they study most

Chronic Plaque-type Psoriasis, Moderate to Severe Plaque-type Psoriasis, Plaque Psoriasis, Plaque-type Psoriasis, Psoriatic Arthritis

Studies at this site

• Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis — Completed
• First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks — Completed
• AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis — Completed
• Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) — Completed
• AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis — Completed